Mast cell modulation of the immune response

Current Allergy and Asthma Reports

Volumn 9, Issue 5, 2009, Pages 353-359

  Ryan, John J ^a   Fernando, Josephine F ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; FC RECEPTOR; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OX40 LIGAND; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOLIPASE C GAMMA; PROTEIN KINASE SYK; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; ALLERGIC ENCEPHALITIS; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ATOPY; CELL ACTIVATION; CELL FUNCTION; CELL INTERACTION; CELL MIGRATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; EOSINOPHIL; HISTAMINE RELEASE; HUMAN; HYPERSENSITIVITY REACTION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INFLAMMATION; MAST CELL; MULTIPLE SCLEROSIS; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; CELL COMMUNICATION; CYTOKINES; HUMANS; IMMUNE TOLERANCE; IMMUNITY, ACTIVE; IMMUNOGLOBULIN E; IMMUNOLOGIC FACTORS; INFLAMMATION; MAST CELLS; PROTEIN KINASES; RECEPTORS, IGE; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 68949101513     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-009-0052-z     Document Type: Review

References (48)

1. Chen CC, Grimbaldeston MA, Tsai M, et al.: Identification of mast cell progenitors in adult mice. Proc Natl Acad Sci U S A 2005, 102:11408-11413.
2. Huff JJR: Biology of mast cells. In Middleton's Allergy Principles and Practices, edn 6, vol 1. Edited by Franklin N, Adkinson JWY, Busse WW, et al. St. Louis, MO: Mosby; 2003:333-359.
3. Metcalfe DD, Baram D, Mekori YA: Mast cells. Physiol Rev 1997, 77:1033-1079.
4. Sayed BA, ChrTsty A, Quirion MR, Brown MA: The master switch: the role of mast cells in autoimmunity and tolerance. Annu Rev Immunol 2008, 26:705-739.
5. Galli SJ, Nakae S, Tsai M: Mast cells in the development of adaptive immune responses. Nat Immunol 2005, 6:135-142.
6. Galli SJ, Kalesnikoff J, Grimbaldeston MA, et al.: Mast cells as "tunable" effector and immunoregulatory cells: Recent advances. Annu Rev Immunol 2005, 23:749-786.
7. Malveaux FJ, Conroy MC, Adkinson NF Jr, Lichtenstein LM: IgE receptors on human basophils. Relationship to serum IgE concentration. J Clin Invest 1978, 62:176-181.
8. Ryan JJ, Kashyap A, Bailey D, et al.: Mast cell homeostasis: a fundamental aspect of allergic disease. Crit Rev Immunol 2007, 27:15-32.
9. Kalesnikoff J, Galli SJ: New developments in mast cell biology. Nat Immunol 2008, 9:1215-1223.
10. Saxon A, Kepley C, Zhang K: "Accentuate the negative, eliminate the positive": Engineering allergy therapeutics to block allergic reactivity through negative signaling. J Allergy Clin Immunol 2008, 121:320-325.
11. Rivera J, Gilfillan AM: Molecular regulation of mast cell activation. J Allergy Clin Immunol 2006, 117:1214-1225; quiz 1226.
12. Kraft S, Kinet JP: New developments in FcepsilonRI regulation, function and inhibition. Nat Rev Immunol 2007, 7:365-378.
13. Gilfillan AM, Rivera J: The tyrosine kinase network regulating mast cell activation. Immunol Rev 2009, 228:149-169.
14. YamashitG Y, Charles N, Furumoto Y, et al.: Cutting edge: genetic variation influences Fc epsilonRI-induced mast cell activation and allergic responses. J Immunol 2007, 179:740-743.
15. Furumoto Y, Gonzalez-Espinosa C, Gomez G, et al.: Rethinking the role of Src family protein tyrosine kinases in the allergic response: New insights on the functional coupling of the high affinity IgE receptor. Immunol Res 2004, 30:241-253.
16. Daeron M, Malbec O, Latour S, et al.: Regulation of tyrosine-containing activation motif-dependent cell signalling by Fc gamma RII. Immunol Lett 1995, 44:119-123.
17. Grimbaldeston MA, Metz M, Yu M, et al.: Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses. Curr Opin Immunol 2006, 18:751-760.
18. Galli SJ, Grimbaldeston M, Tsai M: Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 2008, 8:478-486.
19. Mazzoni A, Siraganian RP, Leifer CA, Segal DM: Dendritic cell modulation by mast cells controls the Th1/Th2 balance in responding T cells. J Immunol 2006, 177:3577-3581.
20. Gregory GD, Raju SS, Winandy S, Brown MA: Mast cell IL-4 expression is regulated by Ikaros and influences encephalitogenic Th1 responses in EAE. J Clin Invest 2006, 116:1327-1336.
21. Yao Y, Li W, Kaplan MH, Chang CH: Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells. J Exp Med 2005, 201:1899-1903.
22. Kambayashi T, Baranski JD, Baker RG, et al.: Indirect involvement of allergen-captured mast cells in antigen presentation. Blood 2008, 111:1489-1496.
23. Shevach EM: From vanilMa to 28 flavors: multiple varieties of T regulatory cells. Immunity 2006, 25:195-201.
24. Lu LF, Lind EF, Gondek DC, et al.: Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006, 442:997-1002.
25. Gri G, Piconese S, Frossi B, et al.: CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 2008, 29:771-781.
26. Kashyap M, Thornton AM, Norton SK, et al.: Cutting edge: CD4 T cell-mast cell interactions alter IgE receptor expression and signaling. J Immunol 2008, 180:2039-2043.
27. Barnstein BO, Li G, Wang Z, et al.: Stat5 expression is required for IgE-mediated mast cell function. J Immunol 2006, 177:3421-3426.
28. Boyce JA, AusteN KF: No audible wheezing: nuggets and conundrums from mouse asthma models. J Exp Med 2005, 201:1869-1873.
29. Nakae S, Suto H, Berry GJ, Galli SJ: Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice. Blood 2007, 109:3640-3648.
30. Rozniecki JJ, Hauser SL, Stein M, et al.: Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann Neurol 1995, 37:63-66.
31. Tuomisto L, Kilpelainen H, Riekkinen P: Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosis. Agents Actions 1983, 13:255-257.
32. Lock C, Hermans G, Pedotti R, et al.: Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 2002, 8:500-508.
33. Dietsch GN, Hinrichs DJ: The role of mast cells in the elicitation of experimental allergic encephalomyelitis. J Immunol 1989, 142:1476-1481.
34. Brenner T, Soffer D, Shalit M, Levi-Schaffer F: Mast cells in experimental allergic encephalomyelitis: Characterization, distribution in the CNS and in vitro activation by myelin basic protein and neuropeptides. J Neurol Sci 1994, 122:210-213.
35. Levi-Schaffer F, Riesel N, Soffer D, et al.: Mast cell activity in experimental allergic encephalomyelitis. Mol Chem Neuropathol 1991, 15:173-184.
36. Secor VH, Secor WE, Gutekunst CA, Brown MA: Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med 2000, 191:813-822.
37. Gregory GD, Robbie-Ryan M, Secor VH, et al.: Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis. Eur J Immunol 2005, 35:3478-3486.
38. Robbie-RBan M, Tanzola MB, Secor VH, Brown MA: Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. J Immunol 2003, 170:1630-1634.
39. Tanzola MB, Robbie-Ryan M, Gutekunst CA, Brown MA: Mast cells exert effects outside the central nervous system to in uence experimental allergic encephalomyelitis disease course. J Immunol 2003, 171:4385-4391.
40. McLachlan JB, Hart JP, Pizzo SV, et al.: Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat Immunol 2003, 4:1199-1205.
41. Sospedra M, Martin R: Immunology of multiple sclerosis. Annu Rev Immunol 2005, 23:683-747.
42. Hart PH, Grimbaldeston MA, Swift GJ, et al.: Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J Exp Med 1998, 187:2045-2053.
43. Byrne SN, Limon-Flores AY, Ullrich SE: Mast cell migration from the skin to the draining lymph nodes upon ultraviolet irradiation represents a key step in the induction of immune suppression. J Immunol 2008, 180:4648-4655.
44. Depinay N, Hacini F, Beghdadi W, et al.: Mast cell-dependent down-regulation of antigen-specific immune responses by mosquito bites. J Immunol 2006, 176:4141-4146.
45. Grimbaldeston MA, Nakae S, Kalesnikoff J, et al.: Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 2007, 8:1095-1104.
46. Metz M, Piliponsky AM, Chen CC, et al.: Mast cells can enhance resistance to snake and honeybee venoms. Science 2006, 313:526-530.
47. Schneider LA, Schlenner SM, Feyerabend TB, et al.: Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin. J Exp Med 2007, 204:2629-2639.
48. Plaut M, Pierce JH, Watson CJ, et al.: Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature 1989, 339:64-67.